SC
DSCI

Scotia Capital’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Scotia Capital’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,000
Closed -$126K – 646
2014
Q1 		$126K Sell
10,000
-1,250
-11% -$16.2K ﹤0.01% 546
2013
Q4 		$122K Buy
+11,250
New +$131K ﹤0.01% 521

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Scotia Capital's DSCI Position: Q2 2014 in Review

Scotia Capital sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q2 2014, closing a stake of 10,000 shares — an estimated $126K sold.

Scotia Capital first reported a position in DSCI in Q4 2013 and held it in 2 quarters. The position peaked at $126K in Q1 2014. 73 funds tracked by Wall St. Rank hold DSCI as of Q2 2014.

  • Scotia Capital reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q2 2014 after selling out during the quarter.
  • Scotia Capital sold 10,000 Derma Sciences, Inc. Common Stock (DE) shares in Q2 2014, an estimated $126K.
  • Scotia Capital first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q4 2013 and held it in 2 quarters.
  • Scotia Capital's Derma Sciences, Inc. Common Stock (DE) position peaked at $126K in Q1 2014.
  • 73 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q2 2014.

Based on Scotia Capital's 13F filing for Q2 2014, filed 14 Aug 2014.